Cargando…
Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant Staphylococcus aureus
The infection of the bone marrow system caused by methicillin-resistant Staphylococcus aureus (MRSA) leads to a variety of common diseases which usually occur in children under the age of 12. Vancomycin (VCM) is the first-line therapy for MRSA-caused serious infections such as bacteremia, infective...
Autores principales: | Lv, Chanmei, Lv, Jiantao, Liu, Yue, Liu, Qifeng, Zou, Dongna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307395/ https://www.ncbi.nlm.nih.gov/pubmed/32567423 http://dx.doi.org/10.1177/2058738420925713 |
Ejemplares similares
-
P199: Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus
por: Lee, MS, et al.
Publicado: (2013) -
Gene Expression Analysis of Children with Acute Hematogenous Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus: Correlation with Clinical Severity of Illness
por: Gaviria-Agudelo, Claudia, et al.
Publicado: (2014) -
Genomic Heterogeneity of Methicillin Resistant Staphylococcus aureus Associated with Variation in Severity of Illness among Children with Acute Hematogenous Osteomyelitis
por: Gaviria-Agudelo, Claudia, et al.
Publicado: (2015) -
The impact of Staphylococcus aureus genomic variation on clinical phenotype of children with acute hematogenous osteomyelitis
por: Collins, Angela, et al.
Publicado: (2018) -
Resolution of Staphylococcus aureus (methicillin-resistant Staphylococcus aureus) osteomyelitis by oral linezolid
por: Gomes, PN, et al.
Publicado: (2003)